|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Aegerion Pharmaceuticals, Inc. (AEGR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
31,480,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.97 - $1.97 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith Sandford D |
Director |
– • – |
2013-08-09 |
4 |
OE |
$15.00 |
$160,518 |
D/D |
10,000 |
10,000 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-07-15 |
4 |
AS |
$77.28 |
$157,546 |
D/D |
(2,000) |
0 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-07-15 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-06-17 |
4 |
AS |
$63.05 |
$391,620 |
D/D |
(6,000) |
0 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-06-17 |
4 |
OE |
$13.01 |
$78,060 |
D/D |
6,000 |
6,000 |
|
- |
|
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
– – • |
2013-06-15 |
4 |
OE |
$25.00 |
$5,000,000 |
I/I |
200,000 |
3,573,426 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-05-15 |
4 |
AS |
$47.32 |
$283,930 |
D/D |
(6,000) |
0 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-05-15 |
4 |
OE |
$13.01 |
$78,060 |
D/D |
6,000 |
6,000 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-04-22 |
4 |
AS |
$40.40 |
$244,451 |
D/D |
(6,000) |
0 |
|
- |
|
| Sumeray Mark |
Chief Medical Officer |
• – – |
2013-04-22 |
4 |
OE |
$13.01 |
$78,060 |
D/D |
6,000 |
6,000 |
|
- |
|
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
– – • |
2013-02-01 |
4 |
B |
$27.79 |
$1,389,400 |
I/I |
50,000 |
3,373,426 |
1.5 |
- |
|
| Carter Martha J |
Chief Regulatory Officer & SVP |
• – – |
2013-01-23 |
4 |
B |
$27.81 |
$13,905 |
D/D |
500 |
1,500 |
2.74 |
- |
|
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
– – • |
2013-01-18 |
4 |
B |
$27.62 |
$1,381,000 |
I/I |
50,000 |
3,323,426 |
1.5 |
- |
|
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
– – • |
2013-01-17 |
4 |
B |
$26.73 |
$1,336,285 |
I/I |
50,000 |
3,273,426 |
1.5 |
- |
|
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
– – • |
2013-01-11 |
4 |
B |
$26.64 |
$12,857,220 |
I/I |
475,000 |
3,223,426 |
1.5 |
- |
|
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
– – • |
2012-12-04 |
4 |
B |
$21.27 |
$425,400 |
I/I |
20,000 |
2,615,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-29 |
4 |
B |
$22.71 |
$681,300 |
I/I |
30,000 |
2,595,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-28 |
4 |
B |
$21.76 |
$1,523,200 |
I/I |
70,000 |
2,565,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-21 |
4 |
B |
$20.75 |
$415,000 |
I/I |
20,000 |
2,495,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-20 |
4 |
B |
$21.01 |
$420,200 |
I/I |
20,000 |
2,475,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-15 |
4 |
B |
$19.50 |
$195,000 |
I/I |
10,000 |
2,455,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-07 |
4 |
B |
$21.12 |
$633,600 |
I/I |
30,000 |
2,445,293 |
1.5 |
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
133,133 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-11-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,415,293 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2012-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
133,133 |
|
- |
|
251 Records found
|
|
Page 5 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
